Canton Strategic Holdings (CNTN) Other financing activities (2022 - 2026)
Canton Strategic Holdings posted quarterly Other financing activities of $3.6 million for Q1 2026, down 59.36% on a QoQ basis from $8.8 million in Q4 2025.
Canton Strategic Holdings (CNTN) has 4 years of Other financing activities data on file, last reported at $3.6 million in Q1 2026.
- For the quarter ending Q1 2026, Other financing activities changed N/A year-over-year to $3.6 million; the trailing twelve-month figure through Mar 2026 stood at $13.5 million (changed N/A YoY), and the FY2025 full-year result was $10.0 million, up 1408.44% from the prior year.
- Other financing activities for Q1 2026 stood at $3.6 million, down from $8.8 million in the prior quarter.
- Across five years, Other financing activities topped out at $8.8 million in Q4 2025 and bottomed at $138450.0 in Q3 2024.
- The 4-year median for Other financing activities is $737009.5 (2022), against an average of $2.4 million.
- Peak annual rise in Other financing activities reached 4191.95% in 2025, while the deepest fall reached 588.14% in 2025.
- A 4-year view of Other financing activities shows it stood at $521294.0 in 2022, then plunged by 60.86% to $204029.0 in 2024, then soared by 4191.95% to $8.8 million in 2025, then sank by 59.36% to $3.6 million in 2026.
- The last three Other financing activities figures came in at $3.6 million (Q1 2026), $8.8 million (Q4 2025), and $952725.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Canton Strategic Holdings | 643.89 Mn | 602.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.56 Mn |
| Mar 31, 2026 | 3.56 Mn |
| Dec 31, 2025 | 8.76 Mn |
| Dec 31, 2025 | 8.76 Mn |
| Sep 30, 2025 | 952,725.00 |
| Sep 30, 2025 | 952,725.00 |
| Dec 31, 2024 | 204,029.00 |
| Dec 31, 2024 | 204,029.00 |
| Sep 30, 2024 | 138,450.00 |
| Sep 30, 2024 | 138,450.00 |
| Mar 31, 2022 | 521,294.00 |
| Mar 31, 2022 | 521,294.00 |